MedPath

Hyoscyamine Sulfate

Hyoscyamine Sulfate Extended-ReleaseTablets, USP 0.375 mg

Approved
Approval ID

3a200492-c460-4b19-ac16-b64493904b88

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 8, 2010

Manufacturers
FDA

Franklin Pharmaceutical LLC

DUNS: 961561581

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

HYOSCYAMINE SULFATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50532-115
Product Classification
G
Generic Name
HYOSCYAMINE SULFATE
Product Specifications
Route of AdministrationORAL
Effective DateApril 8, 2010
FDA Product Classification

INGREDIENTS (7)

DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
ETHYLCELLULOSEInactive
Code: 7Z8S9VYZ4B
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
Stearic AcidInactive
Code: 4ELV7Z65AP
Classification: IACT
Lactose MonohydrateInactive
Code: EWQ57Q8I5X
Classification: IACT
Magnesium StearateInactive
Code: 70097M6I30
Classification: IACT
HYOSCYAMINE SULFATEActive
Quantity: 0.375 mg in 1 1
Code: F2R8V82B84
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hyoscyamine Sulfate - FDA Drug Approval Details